| Name | Title | Contact Details |
|---|---|---|
Eric Peterson |
Director Information Security Operations | Profile |
Deepak Suri |
Chief Information Officer | Profile |
Russell Proulx |
Chief Information Security Officer | Profile |
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Inflo Health is a company that helps imaging centers and hospitals realize more revenue and provide the best patient outcomes.
Blood Systems Laboratories (BSL) is a non-profit organization which consists of three Clinical Laboratories: Immunohematology Reference Laboratory, Histocompatibility Laboratory and Stem Cell Processing Laboratory.
The mission of New Mexico Department of Health is to promote health and wellness, improve health outcomes, and assure safety net services for all people in New Mexico.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.